Hypotension Prediction Index (HPI) and Assisted Fluid Management (AFM) for Perioperative Hemodynamic Optimization in Patients Under General Anesthesia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational and Kapodistrian University of Athens

About this trial

This study investigates if the Hypotension Prediction Index (HPI) combined with the Assisted Fluid Management (AFM) software can improve perioperative hemodynamic management in adult patients undergoing general anesthesia. The main question is :

Does the HPI and AFM software reduce the incidence and duration of intraoperative hypotension? Does the HPI and AFM software optimize fluid and vasopressor administration? Does the HPI and AFM software improve perioperative outcomes? Participants will be randomly allocated to either an experimental group receiving goal directed hemodynamic therapy guided by HPI and AFM or a control group receiving conventional hemodynamic management.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years

Intraoperative monitoring > 2 hours or general anesthesia > 2 hours

Invasive arterial pressure monitoring

Target MAP ≥ 65 mm Hg intraoperatively

Disqualifiers

Target MAP other than 65 mm Hg

Severe preoperative hypotension (MAP < 65 mm Hg)

Severe heart failure (e.g. LVEF < 20%)

Emergency surgery

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acumen IQ sensor with Hypotension Prediction Index (HPI) and Assisted Fluid Management (AFM) software

    Device

    The Acumen IQ sensor will be used with the Hemosphere monitor to guide goal-directed hemodynamic therapy. HPI predicts impending hypotension and AFM guides fluid administration. Clinicians will follow a protocol algorithm to prevent or treat intraoperative hypotension with fluids, vasopressors or inotropes.

  • Conventional Intraoperative Hemodynamic management

    Other intervention

    Participants receive hemodynamic management based on the anesthesiologist's clinical judgement. The Acumen IQ sensor will be placed , but HPI and AFM outputs are not visible to the clinician.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: HPI/AFM - Goal- Directed Hemodynamic TherapyExperimental treatment 1 intervention
Group B: Conventional therapyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time-weighted average of intraoperative hypotension

Time weighted average spent in hypotension, defined as mean arterial pressure (MAP) \<65mmHg for ≥ 1min, measures using the Acumen IQ sensor and Hemosphere monitor.

Time frame
Intraoperatively, starting 10 minutes after anesthesia induction or start of sedation

Secondary outcomes

1

Incidence of hypotension

Incidence of hypotension, defined as MAP \<65mmHg for ≥ 1min.

Time frame
Intraoperatively, starting 10 minutes after anesthesia induction or start of sedation
2

Time spent in hypotension

Time spent in hypotension, in minutes, defined as MAP \<65mmHg for ≥ 1min

Time frame
Intraoperatively, starting 10 minutes after anesthesia induction or start of sedation
3

Choice of therapy (fluids/medications)

Medication used to prevent/treat hypotension. A study member is present at the OR to make notes.

Time frame
Intraoperatively, starting 10 minutes after anesthesia induction or start of sedation
4

Dose of therapy (fluids/medications)

Dose of medication used to prevent/treat hypotension.

Time frame
Intraoperatively, starting 15 minutes after anesthesia induction.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National and Kapodistrian University of Athens

Lead sponsor

Attikon Hospital

Sponsor institution

Attikon Hospital

Collaborator